Search Results - Ding, Sher Min

  • Showing 1 - 5 results of 5
Refine Results
  1. 1
    Deciphering toxico-proteomics of Asiatic medically significant venomous snake species: A systematic review and interactive data dashboard

    Deciphering toxico-proteomics of Asiatic medically significant venomous snake species: A systematic review and interactive data dashboard by Ding, Sher Min, Yap, Michelle Khai Khun

    Published in Toxicon (Oxford)
    Get full text
    Items that this one cites
    Article
    Save to List
    Saved in:
  2. 2
    Clinical outcomes in patients with chronic lymphocytic leukemia with disease progression on ibrutinib

    Clinical outcomes in patients with chronic lymphocytic leukemia with disease progression on ibrutinib by Hampel, Paul J., Rabe, Kari G., Call, Timothy G., Ding, Wei, Leis, Jose F., Chanan-Khan, Asher A., Kenderian, Saad S., Muchtar, Eli, Wang, Yucai, Ailawadhi, Sikander, Koehler, Amber B., Parrondo, Ricardo, Schwager, Susan M., Sher, Taimur, Hanson, Curtis A., Shi, Min, Van Dyke, Daniel L., Braggio, Esteban, Slager, Susan L., Kay, Neil E., Parikh, Sameer A.

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    Outcomes of Patients with Chronic Lymphocytic Leukemia (CLL) Treated with the Combination of Ibrutinib (I) and Venetoclax (V; I+V) after Progression on I Alone (V-naïve) or after Progression on Sequential I and V (Double-Refractory)

    Outcomes of Patients with Chronic Lymphocytic Leukemia (CLL) Treated with the Combination of Ibrutinib (I) and Venetoclax (V; I+V) after Progression on I Alone (V-naïve) or after P... by Hampel, Paul J., Rabe, Kari G., Call, Timothy G., Ding, Wei, Leis, Jose F., Chanan-Khan, Asher, Kenderian, Saad S., Muchtar, Eli, Wang, Yucai, Ailawadhi, Sikander, Koehler, Amber, Schwager, Susan M., Sher, Taimur, Hanson, Curtis A., Shi, Min, Van Dyke, Daniel L., Braggio, Esteban, Slager, Susan L., Kay, Neil E., Parikh, Sameer A.

    Published in Blood
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    CLL-506 Clinical Outcomes Beyond Progression on Ibrutinib in Patients With Chronic Lymphocytic Leukemia

    CLL-506 Clinical Outcomes Beyond Progression on Ibrutinib in Patients With Chronic Lymphocytic Leukemia by Hampel, Paul, Rabe, Kari, Call, Timothy, Ding, Wei, Leis, Jose, Chanan-Khan, Asher, Kenderian, Saad, Muchtar, Eli, Wang, Yucai, Ailawadhi, Sikander, Koehler, Amber, Parrondo, Ricardo, Schwager, Susan, Sher, Taimur, Hanson, Curtis, Shi, Min, Van Dyke, Daniel, Braggio, Esteban, Slager, Susan, Kay, Neil, Parikh, Sameer

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  5. 5
    Poster: CLL-506 Clinical Outcomes Beyond Progression on Ibrutinib in Patients With Chronic Lymphocytic Leukemia

    Poster: CLL-506 Clinical Outcomes Beyond Progression on Ibrutinib in Patients With Chronic Lymphocytic Leukemia by Hampel, Paul, Rabe, Kari, Call, Timothy, Ding, Wei, Leis, Jose, Chanan-Khan, Asher, Kenderian, Saad, Muchtar, Eli, Wang, Yucai, Ailawadhi, Sikander, Koehler, Amber, Parrondo, Ricardo, Schwager, Susan, Sher, Taimur, Hanson, Curtis, Shi, Min, Van Dyke, Daniel, Braggio, Esteban, Slager, Susan, Kay, Neil, Parikh, Sameer

    Get full text
    Article
    Save to List
    Saved in:

Search Tools: